Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma

Surgery

Volumn 132, Issue 1, 2002, Pages 41-47

  Shimada, Hideaki ^a   Nabeya, Yoshihiro ^a   Okazumi, Shin Ichi ^a   Matsubara, Hisahiro ^a   Funami, Yutaka ^a   Shiratori, Tooru ^a   Hayashi, Hideki ^a   Takeda, Akihiko ^a   Ochiai, Takenori ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; PROTEIN P53; TUMOR ANTIGEN;

ADULT; AGED; ANTIBODY TITER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGUS CANCER; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

EID: 0036079102     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2002.125307     Document Type: Article

References (25)

1. Multi factorial analysis of p53 alteration in human cancer: A review
2. Frequent mutation of the p53 gene in human esophageal cancer
3. p53 protein accumulation and p53 gene mutation in esophageal carcinoma
4. p53 protein expression and prognosis in squamous cell carcinoma of the esophagus
5. p53 sequence analysis predicts treatment response and outcome of patients with esophageal carcinoma
6. Circulating anti-p53 antibodies in esophageal cancer patients are found predominantly in individuals with p53 core domain mutations in their tumors
7. Serum anti-p53 antibodies in patients with squamous cell carcinoma of the esophagus: Comparison with p53 alterations and lymph node invasion
8. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: Correlation with clinicopathologic features and tumor markers
9. A study on p53 protein and anti-p53 antibodies in the sera of patients with esophageal cancer
10. Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous cell carcinoma in India
11. A symptomatically efficient rank invariant test procedures
12. A network algorithm for performing fisher's exact test in r x c contingency tables
13. CYFRA21-1 determination in patients with esophageal squamous cell carcinoma
14. Tumor antigen TA-4: An aid in detecting post-operative recurrences of esophageal carcinoma
15. Monitoring of p53 autoantibodies in lung cancer during therapy: Relationship to response to treatment
16. Detection and monitoring of serum p53 antibodies in patients with colorectal cancer
17. p53 and follow-up of colorectal cancer
18. Analysis of p53 serum antibodies in patients with head and neck squamous cell carcinoma
19. Presence of serum anti-p53 antibodies is associated with pleural effusion and poor prognosis in lung cancer patients
20. Circulating antibodies against p53 protein in patients with ovarian carcinoma
21. Correlations between p53-protein accumulation, serum antibodies and gene mutation in colorectal cancer
22. Clinical implications of serum anti-p53 antibodies for patients with gastric carcinoma
23. Serum p53 antibodies: Predictors of survival in small-cell lung cancer?
24. Serum p53 antibodies in small cell lung cancer: The lack of prognostic relevance